' '
Deutsch | English    

Forschungsdatenbank PMU-SQQUID

New Perspectives in Biofilm Eradication.
Wolfmeier, H; Pletzer, D; Mansour, SC; Hancock, REW;
ACS Infect Dis. 2018; 4(2): 93-106.
Letter

PMU-Autor/inn/en

Wolfmeier Heidi

Abstract

Microbial biofilms, which are elaborate and highly resistant microbial aggregates formed on surfaces or medical devices, cause two-thirds of infections and constitute a serious threat to public health. Immunocompromised patients, individuals who require implanted devices, artificial limbs, organ transplants, or external life support and those with major injuries or burns, are particularly prone to become infected. Antibiotics, the mainstay treatments of bacterial infections, have often proven ineffective in the fight against microbes when growing as biofilms, and to date, no antibiotic has been developed for use against biofilm infections. Antibiotic resistance is rising, but biofilm-mediated multidrug resistance transcends this in being adaptive and broad spectrum and dependent on the biofilm growth state of organisms. Therefore, the treatment of biofilms requires drug developers to start thinking outside the constricted "antibiotics" box and to find alternative ways to target biofilm infections. Here, we highlight recent approaches for combating biofilms focusing on the eradication of preformed biofilms, including electrochemical methods, promising antibiofilm compounds and the recent progress in drug delivery strategies to enhance the bioavailability and potency of antibiofilm agents.


Useful keywords (using NLM MeSH Indexing)

Anti-Infective Agents/pharmacology*

Bacterial Infections/drug therapy

Bacterial Infections/microbiology

Biofilms/drug effects*

Drug Delivery Systems

Drug Resistance, Bacterial

Electrochemical Techniques

Humans


Find related publications in this database (Keywords)

biofilms
antibiofilm approaches
biofilm dispersal
electrochemical methods
drug delivery